Founded in 1999 in Ft. Myers, EmCyte Corporation® is the global leader in platelet-rich plasma and progenitor stem cell biologics, dedicated to innovation that makes a clinical difference. Their proprietary product, PurePRP® SupraPhysiologic (PurePRP® SP), is a powerful autologous platelet-rich plasma used to treat and repair various injuries and conditions. PurePRP® SP stands out by providing a high concentration of deliverable regenerative cells while removing harmful factors, making it a preferred choice over surgery for many conditions. With so many PRP kit options and claims in the market, you can rest assured that EmCyte's FDA-registered 510(k) clearance (BK050055) ensures safety, quality, and regulatory compliance. With over 20 years of experience, EmCyte continues to set the highest performance standards in regenerative medicine.